NeoStem announces plans to change name to Caladrius Biosciences
NeoStem announced plans to change its corporate name to Caladrius Biosciences. PCT (Progenitor Cell Therapy, a wholly-owned subsidiary of NeoStem, will be renamed “PCT, a Caladrius company.
May 29, 2015